ASEP Medical Holdings Inc. (CSE:ASEP)
Canada · Delayed Price · Currency is CAD | Market Cap | 2.22M -60.0% |
| Revenue (ttm) | 336.77K +13.5% |
| Net Income | -4.56M |
| EPS | -0.41 |
| Shares Out | 15.87M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,750 |
| Open | 0.1500 |
| Previous Close | 0.1300 |
| Day's Range | 0.1400 - 0.1500 |
| 52-Week Range | 0.0900 - 0.5000 |
| Beta | -1.84 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 24, 2026 |
About ASEP Medical Holdings
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, antibiotic synergy, and immune modulating; diagnostic kits for predicting the onset of severe sepsis; and medical devices with anti-microbial and antifouling coating. The company was formerly known as Trenchant Life S... [Read more]
Financial Performance
In 2025, ASEP Medical Holdings's revenue was 336,773, an increase of 13.17% compared to the previous year's 297,586. Losses were -4.92 million, -40.57% less than in 2024.
Financial StatementsNews
CSE Bulletin: Reinstatement - ASEP Medical Holdings Inc. (ASEP)
Toronto, Ontario--(Newsfile Corp. - Le 18 décembre/December 2025) - Effective immediately, ASEP Medical Holdings Inc. will be reinstated for trading. The Company has rectified the default situation th...
CSE Bulletin: Consolidation - ASEP Medical Holdings Inc. (ASEP)
Toronto, Ontario--(Newsfile Corp. - Le 15 avril/April 2025) - ASEP Medical Holdings Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolid...
Asep Medical Featured in National Documentary
Asep was selected to be a part of a special series titled Empowered, Hosted by Meg Ryan, focusing on science, technology and medicine leaders. VANCOUVER, BC , Aug. 1, 2024 /PRNewswire/ - Asep Medical ...
Asep Joint Venture Company, SepSMART, obtains Business License and is Formally Registered in China
VANCOUVER, BC , April 5, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep" or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that its joint venture company with ...
Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar this Friday, March 22, 2024, at 4 pm EST
CLICK HERE TO REGISTER VANCOUVER, BC , March 18, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that it is h...
Asep Medical Confirms the Use of AI - Enables Improved Treatments for Common Biofilm Infections and Rapid Sepsis Diagnostics
VANCOUVER, BC , March 13, 2024 /PRNewswire/ - In a recent presentation to the US Biophysical Society in Philadelphia 1, Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SE...
Asep Medical's Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis
VANCOUVER, BC , Feb. 27, 2024 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that its proprietary gene expression...
ASEP INC. ANNOUNCES CLOSING OF DEBT SETTLEMENT
VANCOUVER, BC , Dec. 28, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, further to its news release of...
Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US
VANCOUVER, BC , Nov. 24, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the Company's AI-based sepsis d...
Asep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc.
VANCOUVER, BC , Nov. 21, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep" or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that, through its subsidiary Sepset ...
Asep Inc. in Final Stage of Approval Process for NASDAQ Listing Registration Statement
VANCOUVER, BC , Nov. 17, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce it is in the final stage of its appr...
Another Breakthrough-- Asep Inc.'s A.I.-Based Sepsis Technology Identifies COVID-19 Severity from a Blood Sample
A recent study led by Asep Inc.'s Founder, Chair and CEO, Dr. Robert E. W. Hancock, concludes that there is hope for improved clinical management of COVID-19 patients by better assessing the severity ...
Asep Inc. Completes Submission of Registration Statement for NASDAQ Listing
VANCOUVER, BC , July 3, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce it has formally filed a confidential ...
Asep Inc. Receives Grant from NanoMedicines Innovation Network (NMIN), Funded by the Government of Canada
The New Grant Will Support Important Pre-clinical Studies VANCOUVER, BC , June 23, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) i...
Asep Inc. Founder, Chair and CEO, Dr. Robert E. W. Hancock, Ranked 4th Best Microbiologist in the World
VANCOUVER, BC , June 20, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is delighted to announce that the Company's Founder, Chair ...
Asep Inc. Undertakes Final Steps Toward NASDAQ Listing
VANCOUVER, BC , June 16, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce it is preparing the final draft...
Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa
Pictured left to right, Dr. Robert E. W. Hancock and Shaikh Isa bin Khalid Al-Khalifa sign the joint venture's definitive agreement.
Asep Inc. Announces Ground-breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies
VANCOUVER, BC , June 2, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) announces the ground-breaking use of artificial intelligence...
Asep Inc. Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange
VANCOUVER, BC , May 30, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that it has engaged Aegis Capita...
Asep Inc. Signs Joint Venture Term Sheet with Leading Chinese Medical Diagnostic Company Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China
VANCOUVER, BC , Jan. 27, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce that it has signed a joint venture term sheet w...
Asep Medical Holdings Inc. to Hold Important Investor Information Webinar on January 24, 2023
Webinar Features Strategic Insights from Asep Inc.'s Senior Executives, including Founder and CEO Dr. Robert E. W. Hancock, CSO Dr. Evan Haney and COO Mr.
Asep Inc. Signs Letter of Intent for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa
VANCOUVER, BC , Jan. 6, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is delighted to announce the recent signing of a Letter of I...
CLARIFICATION - Asep Medical Holdings Inc. Provides Update on its Prior Disclosure Regarding Proprietary Diagnostic & Therapeutic Technologies
VANCOUVER, BC , Dec. 28, 2022 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) at the request of IIROC the Company would like to provide c...
Asep Medical Holdings Inc. Achieves Significant Milestones Addressing Antibiotic Failure Through Proprietary Diagnostic & Therapeutic Technologies
VANCOUVER, BC , Dec. 23, 2022 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, through its subsidiaries Sepse...
Asep Medical Holdings Inc. Announces Grant of Stock Options
VANCOUVER, BC , Nov. 24, 2022 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, for recruitment, incentivizati...